Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial (Q73176018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

placebo-controlled trial

1 reference

inferred from title

cardiovascular disease

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Manfred S. Green

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

S Smetana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Weinstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Z Matas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

U Gafter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Iaina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Knecht

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Weissgarten

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Brunner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Fainaru

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1213-1218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

Cardiac function and hematocrit level

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Cardiac and cerebrovascular disease in chronic uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Comparative studies on different methods of malonaldehyde determination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Which diet for which renal failure: making sense of the options.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Mortality in the CHAOS trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Vitamin E and heart disease: basic science to clinical intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

The effects of alpha-tocopherol on critical cells in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902783-5

7 January 2021

10.1016/S0140-6736(00)02783-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072938%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference